Key result
TyG index gains prominence as an emerging biomarker for cardiovascular risk and prognosis.
This bibliometric analysis demonstrates the growing recognition and wide applicability of the TyG index as a biomarker for cardiovascular risk assessment and prognosis.
This bibliometric analysis highlights the expanding role of the TyG index in metabolic and cardiovascular research. Key clusters such as percutaneous coronary intervention, obesity indicators, arterial stiffness, heart failure, new-onset hypertension, predicting outcomes, and subclinical coronary artery disease emphasize its wide applicability across diverse clinical settings. The keyword "risk" was the most frequently occurring term, underscoring the importance of the TyG index in cardiovascular risk assessment, alongside its growing use in prognostic applications. These findings reflect the increasing recognition of the TyG index as a pivotal biomarker in cardiovascular medicine and encourage further exploration of its clinical integration.
No takes yet. Share an insight, caveat, or question.
Alotaibi et al. (2025) studied Cardiovascular diseases. Triglyceride-glucose (TyG) index was evaluated. Bibliometric analysis of the triglyceride-glucose (TyG) index highlighted its expanding role as a pivotal biomarker for cardiovascular risk assessment and prognostic applications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: